IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,127,437 | +7.0% | 481,902 | +5.8% | 0.31% | +4.0% |
Q1 2023 | $4,790,966 | +89668.9% | 455,415 | +5.7% | 0.30% | +2.7% |
Q4 2022 | $5,337 | -99.9% | 430,775 | +21.3% | 0.29% | +26.7% |
Q3 2022 | $3,678,000 | +0.5% | 355,050 | +11.9% | 0.23% | +5.5% |
Q2 2022 | $3,658,000 | +11.9% | 317,226 | +22.0% | 0.22% | +31.7% |
Q1 2022 | $3,270,000 | -66.1% | 259,943 | -68.6% | 0.17% | -51.2% |
Q4 2021 | $9,651,000 | -17.3% | 827,733 | -7.3% | 0.34% | -18.4% |
Q3 2021 | $11,663,000 | – | 893,070 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |